AGN up +1.34% percent Today $AGN High is at 213.60 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 11:19 AM

AGN up +1.34% percent Today $AGN High is at 213.60 and the Low 207.18 with current volume of 2,404,220.

Recent News posted below.

Allergan Inc AGN other info.
http://investorshangout.com/Allergan-AGN-50031/

AGN Allergan Inc Recent Headline News

Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 8 mins ago
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 211.90 (+2.70), ACT: 260.58 (+12.64), EOG: 97.14 (+0.79), HAL: 49.70 (+0.47), HP: 77.64 (-0.61), MRO: 31.90 (+0.08), BHI: 65.92 (+0.69)

Zacks Investment Ideas feature highlights: Allergan, Actavis, Sketchers and Zeltiq Aesthetics
PR Newswire - 1 hr 48 mins ago
Today, Zacks Investment Ideas feature highlights Features: Allergan (NYSE:AGN-Free Report), Actavis (NYSE:ACT-Free Report), Sketchers (NYSE:SKX-Free Report) and Zeltiq Aesthetics (Nasdaq:ZLTQ-Free Report).
AGN: 211.90 (+2.70)

Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit?
Uncommon Profit Investor - at Seeking Alpha - 2 hrs 45 mins ago

AGN: 211.90 (+2.70), VRX: 141.26 (+4.53), ACT: 260.58 (+12.64)

Downgrade Alert for Allergan (AGN)
Comtex SmarTrend(R) - Tue Nov 18, 6:55AM CST
Allergan (AMEX:AGN) was downgraded from Buy to Neutral at Guggenheim today. The stock closed yesterday at $209.20 on volume of 19.1 million shares, above average daily volume of 2.7 million. In the past 52 weeks, Allergan share prices have been bracketed by a low of $94.98 and a high of $213.91 and closed yesterday at $209.20, 120% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.2%.
AGN: 211.90 (+2.70)

Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us
at The Street - Mon Nov 17, 7:09PM CST
Cramer says this morning's losses and afternoon's gains prove that not all markets need to trade in tandem.
CST: 42.85 (+0.94), BIIB: 305.27 (+2.85), GE: 26.88 (+0.27), NKE: 95.96 (-0.10), HAL: 49.71 (+0.48), TSN: 42.28 (-0.75), GSAT: 2.59 (-0.21), LULU: 44.97 (+0.55), AGN: 211.90 (+2.70), MACK: 8.85 (+0.23), WHR: 176.68 (+1.13), UA: 68.94 (+0.05), DSX: 7.84 (+0.02), ALNY: 91.22 (+2.24), MPC: 93.04 (+0.53), JCP: 7.32 (+0.06), SHW: 240.45 (+1.14), MBLY: 47.87 (+0.89), REGN: 410.99 (+11.34), BHI: 65.92 (+0.69)

Here Are Some Big Caps Poised To Make Gains
at Investor's Business Daily - Mon Nov 17, 5:45PM CST
Several Big Cap 20 stocks have recently broken out of bases, but are still within buy range, or are building new bases and could be good additions to a watch list. Alexion Pharmaceuticals (ALXN) has pulled back and is within the 5% buy zone. The...
AGN: 211.90 (+2.70), ACT: 260.58 (+12.64), VRX: 141.26 (+4.53), V: 250.25 (+0.45), ALXN: 190.04 (+3.26), CTSH: 52.81 (-0.25), MA: 83.52 (+0.32), ADS: 282.76 (+1.88)

Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:30PM CST
Merck's (MRK) anti-PD-1 therapy, Keytruda, met the primary endpoint of progression free survival as compared to chemotherapy in a phase II study (KEYNOTE-002).
AGN: 211.90 (+2.70), MRK: 59.76 (+0.30), ABBV: 65.77 (+0.73), BMY: 58.75 (+0.32)

Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:20PM CST
Bristol-Myers Squibb Company announced encouraging data from the phase III CheckMate - 066 study on immuno-oncology drug Opdivo.
AGN: 211.90 (+2.70), ACT: 260.58 (+12.64), AMAG: 36.40 (+1.64), BMY: 58.75 (+0.32)

NYSE stocks posting largest volume increases
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
AGN: 211.90 (+2.70), HAL: 49.71 (+0.48), BLT: 16.61 (+0.44), DKL: 40.30 (+0.30), BHI: 65.93 (+0.70)

Watch for Allergan to Potentially Pullback After Gaining 5.21% Yesterday
Comtex SmarTrend(R) - Mon Nov 17, 4:28PM CST
Allergan (AMEX:AGN) traded in a range yesterday that spanned from a low of $207.44 to a high of $213.91. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $200.60 on volume of 18.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AGN: 211.90 (+2.70)

Actavis to spend $66 billion on Allergan
By TOM MURPHY - AP - Mon Nov 17, 4:01PM CST
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
1 Comment
DRTX: 24.16 (+0.41), AGN: 211.90 (+2.70), ACT: 260.58 (+12.64), VRX: 141.26 (+4.53), MRK: 59.76 (+0.30), VRX.TO: 159.79 (+5.39)

Halliburton and Allergan are big market movers
AP - Mon Nov 17, 3:33PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
EXH: 36.83 (+0.02), AGN: 211.90 (+2.70), HAS: 56.00 (-0.37), HAL: 49.71 (+0.48), DNR: 9.91 (-0.10), MITL: 10.26 (+0.06), FOLD: 6.37 (-0.33), BHI: 65.93 (+0.70)

Stocks End Mixed As Allergan Jumps On Actavis Deal
at Investor's Business Daily - Mon Nov 17, 3:16PM CST
Major averages pared losses from a late-morning slump to end mixed amid big merger deals and weak economic data. The S&P 500 and Dow Jones industrial average closed fractionally higher, while the Nasdaq fell 0.4%. Volume ran lower across the board in...
AGN: 211.90 (+2.70), VRX: 141.26 (+4.53), ACT: 260.58 (+12.64), SAFM: 86.75 (+1.82), PPC: 31.24 (+0.30), MIK: 21.98 (+0.33), TSN: 42.28 (-0.75)

Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge
at The Street - Mon Nov 17, 3:15PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies momentarily distracts Wall Street from worrying news Japan has fallen into recession in its third quarter.
AMZN: 327.52 (+4.47), HAS: 56.00 (-0.37), ACT: 260.58 (+12.64), VRX: 141.26 (+4.53), JIVE: 6.43 (+0.06), FB: 74.41 (+0.17), HAL: 49.71 (+0.48), DWA: 22.26 (-0.05), AGN: 211.90 (+2.70), LNKD: 224.55 (+1.27), BHI: 65.93 (+0.70), CRM: 63.06 (+0.55)

Stocks Mixed In Afternoon; Allergan Jumps To New High
at Investor's Business Daily - Mon Nov 17, 2:13PM CST
Stocks remained mixed late Monday afternoon as investors weighed a spate of merger activity against news that Japan fell into a recession. The Dow Jones industrial average and the S&P 500 were each up 0.1%, while the Nasdaq was down 0.3%. Volume was...
AGN: 211.90 (+2.70), VRX: 141.26 (+4.53), ACT: 260.58 (+12.64), LNKD: 224.55 (+1.27), FB: 74.41 (+0.17), HAL: 49.71 (+0.48), BHI: 65.93 (+0.70), Z: 117.40 (-0.46)

Most active New York Stock Exchange-traded stocks
AP - Mon Nov 17, 1:22PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:
AGN: 211.90 (+2.70), GE: 26.88 (+0.27), F: 15.29 (-0.25), PFE: 30.54 (+0.22), HAL: 49.71 (+0.48), BAC: 17.20 (+0.11), DNR: 9.91 (-0.10), TWTR: 40.55 (+0.08), BHI: 65.93 (+0.70)

Fitch: Allergan Purchase by Actavis Would Pressure Ratings
Business Wire - Mon Nov 17, 12:44PM CST
Allergan's ratings remain on Rating Watch Negative following Actavis plc's (Actavis) announcement that it plans to acquire Allergan for approximately $66 billion. Allergan presently has $2.1 billion of outstanding debt.
AGN: 211.90 (+2.70)

Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession
at The Street - Mon Nov 17, 12:16PM CST
Wheelings and dealings from top pharmaceutical giants and energy companies distract Wall Street from worrying news Japan had fallen into recession in its third quarter.
AGN: 211.90 (+2.70), HAS: 56.00 (-0.37), AMZN: 327.52 (+4.47), VRX: 141.26 (+4.53), ACT: 260.58 (+12.64), LNKD: 224.55 (+1.27), JIVE: 6.43 (+0.06), FB: 74.40 (+0.16), HAL: 49.71 (+0.48), DWA: 22.26 (-0.05), CRM: 63.06 (+0.55), BHI: 65.93 (+0.70)

Pershing Square wins big on Actavis buy
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 11:22AM CST

AGN: 211.90 (+2.70), ACT: 260.58 (+12.64), VRX: 141.26 (+4.53)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

South Florida Donor Network Honors 52 Heroic Donors

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Sacrifice Unending: 9/11's Lingering Health Toll

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Job Market Shifts: Adaptation vs. Fairness Dilemma

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

CUBEX Lights Up Veterinary Care with Mini Essential

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Fresh Thyme Empowers Local Brands in Michigan Debut

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...